Get started
Author

Alpaslan Özgün

Observed names: ALPASLAN OZGUN, Alpaslan Ozgun, Mehmet Alpaslan Özgün, Ozgun, Alpaslan, ÖZGÜN, Alpaslan, Özgün, Alpaslan
OpenAlex ID: A5078433199
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
2018 · Curtis H. Kugel, Stephen M. Douglass, et al. · Clinical Cancer Research · 367
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
2017 · Eileen Shiuan, Kathryn E. Beckermann, et al. · Journal for ImmunoTherapy of Cancer · 134
PDF
Immunoregulatory Function of HLA-G in Gastric Cancer
2013 · Tolga Tuncel, Bulent Karagoz, et al. · Asian Pacific Journal of Cancer Prevention · 55
PDF
Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy
2014 · Tolga Tunce, Alpaslan Ozgun, et al. · Asian Pacific Journal of Cancer Prevention · 51
PDF
Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma
2017 · Daniel Y. Wang, Zeynep Eroglu, et al. · Cancer Immunology Research · 47
Melanoma brain metastases: Biological basis and novel therapeutic strategies
2021 · Manali Phadke, Alpaslan Ozgun, et al. · Experimental Dermatology · 36
PDF
MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
2013 · Alpaslan Özgün, Bulent Karagoz, et al. · Oncology Research and Treatment · 33
Nesfatin-1 in advanced lung cancer patients with weight loss
2012 · Hakkı Çetinkaya, Bülent Karagöz, et al. · Regulatory Peptides · 22
The inflammatory cytokine interleukin-23 is elevated in lung cancer, particularly small cell type
2016 · Caner Cam, Bulent Karagoz, et al. · Współczesna Onkologia · 14
PDF
Platelet indices in patients with colorectal cancer
2009 · Bülent Karagöz, İlker Sücüllü, et al. · Open Medicine · 14
PDF
Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer
2009 · Bülent Karagöz, Oğuz Bilgi, et al. · Medical Oncology · 13
Updates and challenges on treatment with BRAF/MEK-inhibitors in melanoma
2018 · Zeynep Eroglu, Alpaslan Ozgun · Expert Opinion on Orphan Drugs · 12
Clinicopathological Features and Survival of Young Turkish Patients with Testicular Germ Cell Tumors
2013 · Alpaslan Ozgun, Bulent Karagoz, et al. · Asian Pacific Journal of Cancer Prevention · 10
Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report
2014 · ALPASLAN OZGUN, TOLGA TUNCEL, et al. · Oncology Letters · 9
PDF
Broca’s aphasia due to cerebral venous sinus thrombosis following chemotherapy for small cell lung cancer: A case report and review of literature
2014 · TOLGA TUNCEL, ALPASLAN OZGUN, et al. · Oncology Letters · 7
PDF
Cerebrovascular Accident After Chemotherapy for Testicular Cancer
2009 · Bulent Karagoz, Oguz Bilgi, et al. · Military Medicine · 7
The Clinical Significance of Seminoma Component in Testicular Mixed Germ Cell Tumour
2020 · Serkan Akan, Caner Ediz, et al. · Urologia Internationalis · 6
HLA-G in Testicular Germ Cell Tumors
2014 · Bülent Karagöz, Abdullah Haholu, et al. · Oncology Research and Treatment · 6
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
2022 · Mutlu Hizal, Burak Bilgin, et al. · Journal of Cancer Research and Clinical Oncology · 5
PDF
Clinical immunology CD4+CD25high, CD8+CD28– cells and thyroid autoantibodies in breast cancer patients
2014 · Oğuz Bilgi, Bülent Karagöz, et al. · Central European Journal of Immunology · 5
PDF
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series
2022 · Jessica Louise Smith, Alexander M. Menzies, et al. · Melanoma Research · 4
Neurotoxicity associated with anti-PD1 therapy: A multi-center case series.
2017 · Jess Louise Smith, Alexander M. Menzies, et al. · Journal of Clinical Oncology · 4
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
2022 · Mutlu Hizal, Burak Bilgin, et al. · Future Oncology · 3
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib
2022 · Yakup Iriagac, Eyyup Cavdar, et al. · Journal of Cancer Research and Therapeutics · 3
Resistance patterns to anti-PD-1 therapy in metastatic melanoma
2016 · Alpaslan Ozgun, Vernon K. Sondak, et al. · Chinese Clinical Oncology · 3
Works count: 76
Citation count: 886
H-index: 12
I10-index: 13
Year
Topic
Type